Successful continuous nivolumab therapy for metastatic non‐small cell lung cancer after local treatment of oligometastatic lesions

Successful continuous nivolumab therapy for metastatic non‐small cell lung cancer after local treatment of oligometastatic lesions

Abstract The patient in this report was a 57‐year‐old man with metastatic non‐small cell lung cancer (NSCLC). After no response to two lines of systemic chemotherapy, he was treated with nivolumab as third‐line therapy, which resulted in a partial response. After 17 months of nivolumab treatment, he...

Full description

Bibliographic Details
Main Authors: Satoshi Tobita, Yuhei Kinehara, Yoshio Tamura, Hiroyuki Kurebe, Ryusuke Ninomiya, Yoshihiko Utsu, Satoshi Kohmo, Bunzo Sato, Kenichi Nagai, Shintaro Maruoka, Ryu Jokoji, Shohei Koyama, Isao Tachibana
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Thoracic Cancer
Subjects:
Adaptive resistance
immune checkpoint inhibitors
local treatment
lymphocyte‐activation gene 3
T cell immunoglobulin and mucin domain‐containing protein 3
Online Access:https://doi.org/10.1111/1759-7714.13539

Internet

https://doi.org/10.1111/1759-7714.13539

Similar Items